Real-time enrollment status for this metastatic cancer clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 5:47 PM UTC
| NCT Number | NCT05267626 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Cancer |
| Phase | PHASE1 |
| Target Enrollment | 159 participants |
| Active Locations | 11 sites in the US |
| Sponsor | Aulos Bioscience, Inc. |
| Last Updated on CT.gov | May 18, 2026 (May 18, 2026) |
As of July 17, 2026: Clinical trial NCT05267626 is currently recruiting participants. This phase1 study for metastatic cancer is actively seeking new participants at 11 locations across the United States. The study is sponsored by Aulos Bioscience, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05267626 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05267626 was last updated May 18, 2026 (May 18, 2026). HelloStudys verifies this status automatically.